Sodium valproate compared to phenytoin in treatment of status epilepticus
Sodium valproate compared to phenytoin in treatment of status epilepticus
نویسندگان: هوزان محمدی
کلمات کلیدی: phenytoin, sodium valproate, status epilepticus, tolerability
نشریه: 36757 , 3 , 8 , 2018
| نویسنده ثبت کننده مقاله |
هوزان محمدی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
کمیته تحقیقات دانشجویی |
| کد مقاله |
65422 |
| عنوان فارسی مقاله |
Sodium valproate compared to phenytoin in treatment of status epilepticus |
| عنوان لاتین مقاله |
Sodium valproate compared to phenytoin in treatment of status epilepticus |
| ناشر |
7 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Background: Status epilepticus (SE) is a neurological emergency which can be life-threatening.
Several medical regimens are used in order to control it. In this study, we
intended to evaluate the clinical efficacy and tolerability of sodium valproate and
intravenous phenytoin (IV PHT) in the control of SE.
Methods: One hundred and ten consecutive patients suffering from benzodiazepine
refractory SE who were referred to the emergency ward from March 2014 to March
2015 were randomly divided into two groups. The first group received intravenous
sodium valproate, 30 mg/kg as loading dose and then 4–8 mg/kg every 8 hr as maintenance
regimen. The second group received IV PHT 20 mg/kg as loading dose and
then 1.5 mg/kg for 8 hr as maintenance therapy. All patients were monitored for vital
signs every 2 hr up to 12 hr. The patients were also followed up for 7 days regarding
drug response and adverse effects.
Results: The administration of sodium valproate and phenytoin respectively resulted
in seizure control in 43 (78.18%) and 39 (70.90%) of the patients within 7 days of drug
administration (p = .428). Seven-day
mortality rate was similar in both groups (12.73%
vs. 12.73%; p = .612). There was no significant difference in adverse effects between
two groups.
Conclusion: Sodium valproate is preferred to IV PHT for treatment and control of SE
due to its higher tolerability and lower hemodynamic instability. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| brain impact factor.jpg | 1397/12/12 | 90756 | دانلود |
| 1.jpg | 1397/12/08 | 159115 | دانلود |
| 2.jpg | 1397/12/08 | 107081 | دانلود |
| 3.jpg | 1397/12/08 | 66312 | دانلود |
| Brain & Behavior.pdf | 1397/10/02 | 375490 | دانلود |